CHEBI:28197 - daidzein

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name daidzein
ChEBI ID CHEBI:28197
Definition A member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone substituted by an additional hydroxy group at position 4'.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:4306, CHEBI:23558
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C15H10O4
Net Charge 0
Average Mass 254.23750
Monoisotopic Mass 254.05791
InChI InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-8,16-17H
InChIKey ZQSIJRDFPHDXIC-UHFFFAOYSA-N
SMILES Oc1ccc(cc1)-c1coc2cc(O)ccc2c1=O
Metabolite of Species Details
Cordyceps sinensis (NCBI:txid72228) Found in mycelium (BTO:0001436). Ethanolic extract of dried mycelia See: PubMed
Roles Classification
Biological Role(s): phytoestrogen
Any compound produced by a plant that happens to have estrogenic activity.
plant metabolite
Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
EC 3.2.1.20 (alpha-glucosidase) inhibitor
An EC 3.2.1.* (glycosidase) inhibitor that interferes with the action of alpha-glucosidase (EC 3.2.1.20).
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor
A DNA polymerase inhibitor that interferes with the action of a DNA-directed DNA polymerase (EC 2.7.7.7).
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing daidzein (CHEBI:28197) has role antineoplastic agent (CHEBI:35610)
daidzein (CHEBI:28197) has role EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor (CHEBI:131699)
daidzein (CHEBI:28197) has role EC 3.2.1.20 (α-glucosidase) inhibitor (CHEBI:67239)
daidzein (CHEBI:28197) has role phytoestrogen (CHEBI:76989)
daidzein (CHEBI:28197) has role plant metabolite (CHEBI:76924)
daidzein (CHEBI:28197) is a 7-hydroxyisoflavones (CHEBI:55465)
daidzein (CHEBI:28197) is conjugate acid of daidzein(1−) (CHEBI:77764)
Incoming 2'-hydroxy-2,3-dihydrodaidzein (CHEBI:16035) has functional parent daidzein (CHEBI:28197)
2'-hydroxydaidzein (CHEBI:27479) has functional parent daidzein (CHEBI:28197)
3',4',7-trihydroxyisoflavone (CHEBI:50399) has functional parent daidzein (CHEBI:28197)
4',6,7-trihydroxyisoflavone (CHEBI:74957) has functional parent daidzein (CHEBI:28197)
8-prenyldaidzein (CHEBI:133373) has functional parent daidzein (CHEBI:28197)
daidzein 7-(6-O-acetyl-β-D-glucoside) (CHEBI:133395) has functional parent daidzein (CHEBI:28197)
daidzein 7-O-β-D-glucoside (CHEBI:42202) has functional parent daidzein (CHEBI:28197)
daidzein monosulfate (CHEBI:133579) has functional parent daidzein (CHEBI:28197)
formononetin (CHEBI:18088) has functional parent daidzein (CHEBI:28197)
isoformononetin (CHEBI:29608) has functional parent daidzein (CHEBI:28197)
daidzein(1−) (CHEBI:77764) is conjugate base of daidzein (CHEBI:28197)
IUPAC Name
7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
Synonyms Sources
4',7-dihydroxyisoflavone ChEBI
4',7-dihydroxyisoflavone ChemIDplus
7,4'-dihydroxyisoflavone ChemIDplus
7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone ChEBI
7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one ChemIDplus
Daidzein KEGG COMPOUND
daidzeol ChEBI
isoaurostatin ChEBI
Manual Xrefs Databases
C00009380 KNApSAcK
C10208 KEGG COMPOUND
Daidzein Wikipedia
DAIDZEIN MetaCyc
HMDB0003312 HMDB
LMPK12050038 LIPID MAPS
LSM-2935 LINCS
View more database links
Registry Numbers Types Sources
231523 Reaxys Registry Number Reaxys
231523 Beilstein Registry Number Beilstein
486-66-8 CAS Registry Number KEGG COMPOUND
486-66-8 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
11193416 PubMed citation Europe PMC
16802696 PubMed citation Europe PMC
23267126 PubMed citation Europe PMC
23337939 PubMed citation Europe PMC
23342971 PubMed citation Europe PMC
23439294 PubMed citation Europe PMC
9544566 PubMed citation Europe PMC
Last Modified
27 February 2017